Latest News for Life Stem Genetics Stock (OTC:LIFS)

Life Stem Genetics Inc is a development stage company involved in the establishment of stem cell therapy based clinics.

News

Guidance

Contracts

Management

Global

CRYO

LIFS

Life Stem Genetics, American CryoStem Announce Collaboration

LIFE STEM GENETICS INC by Life Stem Genetics Inc.

Life Stem Genetics Inc

Life Stem Genetics (OTC: <a class="ticker" href="/stock/lifs#OTC">LIFS</a>) announced today a strategic 
 collaborative agreement with American CryoStem Corporation, 
 (OTC: <a class="ticker" href="/stock/cryo#OTC">CRYO</a>). CRYO is a leading developer, marketer and global licensor 
 of patented adipose tissue-based cellular technologies for the 
 Regenerative and Personalized Medicine industries.
 Adipose tissue is an anatomical term for loose connective tissue (fat) 
 composed of adipocytes (cells). It is used in LIFS stem cell procedures 
 and currently is extracted via liposuction each time a patient has a 
 treatment. This collaboration will give our physician's network the 
 ability to store a patient's adipose tissue for future regenerative 
 medicine applications after only one extraction process. In the absence 
 of future liposuction procedures, the patient's recovery time is 
 <a href="http://www.benzinga.com/pressreleases/13/11/b4102538/life-stem-genetics-announces-collaborative-agreement-with-american-cryo">See full press release</a>

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Life Stem Genetics Stock (OTC:LIFS)

Friday, November 22, 2013